13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 36 holding rows worth $167,046,000.
- Accession
- 0001420506-22-000326
- Filer
- CIK 1617201
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 36 entries on the cover page, a total value of $167,046,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $167,046,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTHENA CORP PLC SHS | G72800108 | Stock | 441,000 | $21,785,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 345,900 | $19,069,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 514,082 | $11,973,000 | thousands by filing date | |
| GALAPAGOS NV | 36315X901 | SPON ADR | 200,300 | $11,043,000 | thousands by filing date | call |
| CUE BIOPHARMA INC | 22978P106 | COM | 829,042 | $9,376,000 | thousands by filing date | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 122,187 | $7,974,000 | thousands by filing date | |
| OSCAR HEALTH INC | 687793109 | CL A | 925,000 | $7,261,000 | thousands by filing date | |
| CONVEY HEALTH SOLUTIONS HLDG | 21258C108 | CMN | 777,000 | $6,496,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 360,000 | $6,019,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 362,909 | $5,897,000 | thousands by filing date | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 15,481 | $5,833,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 409,620 | $5,419,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 31,907 | $5,411,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 1,155,300 | $4,621,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 45,000 | $4,182,000 | thousands by filing date | |
| AGILON HEALTH INC | 00857U107 | COM | 150,000 | $4,050,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 72,898 | $3,454,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 356,617 | $2,857,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 128,705 | $2,810,000 | thousands by filing date | |
| PROTHENA CORP PLC | G72800908 | SHS | 52,100 | $2,574,000 | thousands by filing date | call |
| PROGYNY INC | 74340E953 | PUT | 50,000 | $2,518,000 | thousands by filing date | put |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 260,243 | $2,215,000 | thousands by filing date | |
| COGNITION THERAPEUTICS INC | 19243B102 | COM | 301,979 | $1,909,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP II | G6882C106 | COM | 195,855 | $1,900,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 20,188 | $1,458,000 | thousands by filing date | |
| ACCOLADE INC | 00437E102 | COM | 50,000 | $1,318,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 17,364 | $1,316,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 68,800 | $1,313,000 | thousands by filing date | |
| SIO GENE THERAPIES INC | 829399104 | COM | 802,180 | $1,035,000 | thousands by filing date | |
| MODERNA INC | 60770K107 | COM | 3,700 | $940,000 | thousands by filing date | |
| WEST PHARMACEUTICAL SVSC INC | 955306955 | COM | 1,500 | $704,000 | thousands by filing date | put |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 166,775 | $564,000 | thousands by filing date | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 20,000 | $500,000 | thousands by filing date | |
| EXICURE INC | 30205M101 | COM | 2,426,508 | $490,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 298,900 | $404,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 53,815 | $358,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-22-000326 | this filing | 2022-02-14 | acceptance time not in the bulk data set |